Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Guanfacine and glucose metabolism

S Sailer, H J Lisch, W Patsch

    British Journal of Clinical Pharmacology
    |January 1, 1980
    PubMed
    Summary

    Guanfacine, a medication, did not alter blood glucose or insulin levels in a study involving six men. The oral glucose tolerance test showed no significant impact from a single intravenous dose of guanfacine.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First Results on the Search for Lepton Number Violating Neutrinoless Double-β Decay with the LEGEND-200 Experiment.

    Physical review letters·2026
    Same author

    Charge Radii Measurements of Exotic Tin Isotopes in the Proximity of N=50 and N=82.

    Physical review letters·2025
    Same author

    Search for the in-situ production of <math><mmultiscripts><mrow></mrow> <mrow></mrow> <mn>77</mn></mmultiscripts></math> Ge in the GERDA neutrinoless double-beta decay experiment.

    The European physical journal. C, Particles and fields·2025
    Same author

    Measurement of the <sup>85</sup>Kr specific activity in the GERDA liquid argon.

    The European physical journal. C, Particles and fields·2025
    Same author

    Searches for new physics below twice the electron mass with GERDA.

    The European physical journal. C, Particles and fields·2024
    Same author

    Final Results of GERDA on the Two-Neutrino Double-β Decay Half-Life of ^{76}Ge.

    Physical review letters·2023

    Area of Science:

    • Pharmacology
    • Endocrinology
    • Metabolic Studies

    Background:

    • Guanfacine is an alpha-2A adrenergic receptor agonist.
    • Understanding the metabolic effects of medications is crucial for patient safety and treatment efficacy.

    Purpose of the Study:

    • To investigate the impact of a single intravenous dose of guanfacine (1.0 mg) on glucose metabolism.
    • To compare the effects of guanfacine versus placebo on key metabolic markers.

    Main Methods:

    • A randomized, placebo-controlled, cross-over study was conducted with six male participants.
    • An oral glucose tolerance test was administered 90 minutes post-medication administration.

    Main Results:

    • Guanfacine administration showed no significant effect on fasting blood glucose levels.
    • Insulin levels and the 'Insulinogenic index' remained unchanged after guanfacine treatment compared to placebo.

    Conclusions:

    • A single intravenous dose of guanfacine does not appear to affect glucose metabolism in healthy men.
    • Further research may be warranted to explore potential effects in different populations or at varying dosages.

    Related Experiment Videos